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ABSTRACT 
Our objective is to demonstrate an electrospun 
fibrinogen-PDO (polydioxanone) composite scaffold 
will retain the superior cellular interaction of fibrinogen 
while producing a product with the functional strength 
needed for direct implantation.  Fibrinogen-PDO 
composite scaffolds were electrospun with PDO ratios 
of 0% (pure fibrinogen), 10%, 20%, 30%, 40%, 50% 
and 100% (pure PDO) and disinfected using standard 
methods.  Scaffolds were seeded with human BSM 
(bladder smooth muscle cells) and incubated with twice 
weekly media changes.  Samples were removed at 7, 14 
and 21 days for evaluation by collagen assay, scanning 
electron microscopy and histology.  Cell seeding and 
culture demonstrated human BSM readily migrate 
throughout and remodel electrospun fibrinogen-PDO 
composite scaffolds with deposition of native collagen.  
Cell migration and collagen deposition increased with 
increasing fibrinogen concentration while scaffold 
integrity increased with increasing PDO concentration.  
Electrospun fibrinogen-PDO composite structures 
promote rapid cellular in-growth by human BSM while 
maintaining structural integrity.  The fibrinogen to PDO 
ratio can be adjusted to achieve the desired properties 
required for a specific tissue engineering application.   
Our ultimate objective is to utilize this innovative 
biomaterial technology to produce an acellular, 
bioresorbable product that enables in situ tissue 
regeneration.  While there is still much work to be 
done, these initial findings indicate fibrinogen-PDO 
composite scaffolds deserve further investigation. 
 
INTRODUCTION 
The need for urinary tract reconstruction can result 
from a large variety of urologic disorders such as 
congenital hypospadias, stricture disease, cancer and 
trauma.  These disorders may affect the ureters, bladder 
or urethra, decreasing the availability of adequate 
autologous tissue.  Moreover, complications from 
inserting autologous tissue, such as enteric segments, 
into the urinary tract are well known and often 
manifests metabolic and histopathologic abnormalities.  
These sequelae have motivated investigators to search 
for tissue-engineered alternatives.   
 
Ideally, a tissue-engineered scaffold should mimic the 
structural and functional profile of the native 
extracellular matrix (ECM).  To achieve this objective, 
the “ideal” scaffold has been described as having the 
following characteristics: 1) a three-dimensional 
structure with a surface chemistry that promotes cell 
attachment, proliferation and differentiation [1], 2) that 
does not induce adverse immune responses from the 
surrounding tissues [1], 3) mechanical properties to 
withstand organ-specific in vivo forces while being 
completely resorbable [2], and 4) a feasible production 
process that allows for various shapes and sizes [3].   
Despite many recent advances, none of the scaffolds in 
use today meet all of the above mentioned criteria 
completely. 
 
Fibrinogen is a naturally occurring soluble blood 
protein that functions as a major structural element in 
the coagulation cascade, clot formation and wound 
healing [4, 5].  The reaction of fibrinogen with 
thrombin produces fibrin.  This exposes regions of 
opposite charge leading to the assembly of fibrous clots 
and/or other fibrous structures.  These fibrous structures 
function as nature’s provisional matrix, on which 
tissues rebuild and repair themselves, making this type 
of structure an attractive scaffold for tissue engineering 
and regeneration [6-8].  
 
Fibrin and fibrinogen have a well established track 
record in tissue engineering, due to their innate ability 
to induce cellular interaction and subsequent scaffold 
remodeling.  Fibrinogen based scaffolds have 
previously been developed in the form of  fibrin gels [7-
14] and wet extrusion fibronectin-fibrinogen cables [15-
17].  These studies demonstrated fibrinogen based 
scaffolds were easily degradable, nonimunogenic [9] 
and promoted increased cell migration [15, 17]. 
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Volume 3, Issue 2—2008 Electrospinning is a technology with the potential to 
fulfill the requirements of an ideal scaffold.  Briefly, 
electrospinning is accomplished by inducing a large 
electric potential (15 to 30 kilovolts DC) in a polymer 
solution and separating that polymer from an oppositely 
charged target.  This charge separation creates a static 
electric field.  As the field strength grows, the charge 
separation overcomes the surface tension of the solution 
and a thin jet of entangled polymer chains is ejected 
from the polymer reservoir.  As this jet travels toward 
the target, instabilities within the charged jet define its 
orientation in space (condition previously described as 
whipping).  By the time the jet reaches the target, the 
solvent has evaporated and a dry fiber is collected in the 
form of a non-woven scaffold (Figure 1).  
 
 
 
 
 
FIGURE 1: Scanning electron micrographs of electrospun fibrinogen-
PDO composite scaffolds at 2000x magnification.  10% PDO 
composite (top) has a scale bar of 10 μm, while 40% PDO composite 
(bottom) has a scale bar of 5 μm.    
 
 
METHODS 
 
Electrospinning 
For this study, fibrinogen (Bovine soluble fraction 1, 
Sigma Aldrich Chemical Co.) was dissolved in 9 parts 
1,1,1,3,3,3 hexafluoro-2-propanol (HFP, Sigma Aldrich 
Chemical Co.) and 1 part 10X minimal essential 
medium (MEM) at a concentration of 110 mg/mL.   
PDO (Ethicon) was dissolved in HFP at a concentration 
of 100 mg/mL.  These ratios were chosen based on 
previous work conducted by the authors that 
demonstrated the best mechanical and cellular 
interaction characteristics for further investigation.  The 
solutions were then loaded into separate Becton 
Dickinson 5.0-mL syringes and placed in a KD 
Scientific syringe pump.  The fibrinogen solution was 
dispensed at a rate of 1.8 mL/hr.  The dispensing rate of 
the PDO solution was varied to produce scaffolds with 
PDO ratios of 0%, 10%, 20%, 30%, 40%, 50% and 
100% by volume.  The positive output lead of a high 
voltage power supply (Spellman CZE1000R; Spellman 
High Voltage Electronics Corp.), set to 22 kV, was 
attached to a custom designed 2 input - 1 output nozzle 
as depicted in Figure 2.  This nozzle had an estimated 
component mixing length of 15 mm prior to exiting the 
nozzle.  A grounded target (2.5 cm Wide × 10 cm Long 
× 0.3 cm Thick; 303 stainless steel) was placed 10 cm 
from the nozzle tip and rotated at 500 revolutions per 
minute (RPM) to evenly coat the mandrel, but not 
impart a large degree of alignment to the deposited 
fibers.   
 
Mechanical Evaluation  
For determining the bulk mechanical properties, 
samples were incubated at 37ºC for 24 hours in 
complete culture media containing Dulbecco's Modified 
Eagle Medium (DMEM)-F12 Nutrient Mixture (F12) 
(1:1 DMEM:F12) supplemented with 5% Fetal Bovine 
Serum (FBS) and 1.2% penicillin-streptomycin 
antibiotic (10,000 I.U. penicillin/mL, 10,000 µg/mL 
streptomycin, Mediatech, Inc.).  Uniaxial tensile testing 
was performed on a MTS Bionix 200 (MTS Systems 
Corp.) mechanical testing system incorporating a 50 N 
load cell with an extension rate of 10 mm/min to 
failure.  A total of six test specimens (n=6) were tested 
for each study group.  Specimens were punched from 
the scaffolds using a “dog-bone” shaped template to 
assure uniformity and isolate the failure point away 
from the grips.  The specimens had a width of 2.67 mm 
and a gauge length of 11.25 mm.  Specimen thickness 
was measured on a Mitutoyo IP54 digital micrometer 
(Mitutoyo American Corp.) and ranged from 0.03 to 
0.20 mm.  Tangent modulus (tangential method 
automatically selected by the MTS TestWorks 4.0 
software), peak stress (engineering stress based on the 
initial cross-sectional area), and strain to failure (also 
calculated automatically by the software) were 
determined. 
 
Cell Culture  
Experiments were designed to evaluate cell 
proliferation and cell migration into the scaffolds at 
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were electrospun with PDO as previously described.   
Seventy-five 15 mm diameter die-cut scaffold 
specimens, five scaffolds at each concentration at each 
time point, were placed in separate wells of 24 well 
culture plates.  All scaffolds were sanitized in 100% 
ethanol for ten minutes then rinsed four times with 
sterile PBS for three minutes per rinse.  Human BSM 
(Cambrex) were expanded utilizing standard cell 
culture protocol in complete culture media containing 
DMEM:F12 supplemented with the Cambrex BulletKit 
(hEGF, hFGF-B, insulin, gentamicin, amphotericin-B, 
5% fetal bovine serum).  Scaffolds were seeded with 
2x10
4 cells per scaffold.  Culture media was aspirated 
from the scaffold containing test wells and 500 μl of 
fresh media was added to each culture well and 
changed twice per week.  Cultures were incubated at 
37ºC in 5% CO2 and removed for testing at 7, 14 and 
21 days.   
 
 
 
    
FIGURE 2: Diagrammatic representation of the custom designed 
nozzle in a typical electrospinning setup, attached to syringes with 18 
gauge Tygon
® tubing (top) and section view of the 2 input - 1 output 
nozzle (bottom).  
 
 
Collagen Assay 
Collagen deposition by cultured cells was measured 
using the Sircol Collagen Assay (Biocolor).  This is a 
colorimetric assay for the quantification of acid-soluble 
and pepsin-soluble collagens (Types I to IV) extracted 
from mammalian tissues.  The Sircol dye reagent 
contains Sirius Red, which is an anionic dye with 
sulphonic acid side chain groups that react with the side 
chain groups of the basic amino acids present in 
collagen.  The specific affinity of the dye for collagen, 
under the assay conditions, is due to the elongated dye 
molecules becoming aligned parallel to the long, rigid 
structure of native collagens that have intact triple helix 
organization.  Increased collagen content leads to an 
increase in the amount of Sircol dye bound, which is 
measured with a spectrophotometer.   
 
After the 7 and 14 day incubation periods, scaffolds 
were removed from the culture wells and placed in 
separate 1.5 mL centrifuge tubes.  One milliliter of 0.5 
M acetic acid solution containing 1 mg of pepsin was 
added to each centrifuge tube and samples were placed 
on an orbital mixer overnight.  The tubes were gently 
mixed and 100 μL of solution from each tube was 
transferred to a new centrifuge tube.  To develop a 
standard curve, four control solutions were prepared by 
combining 5, 10, 25 and 50 μL (1µg/µL) of reference 
collagen standard with distilled water to total 100 μL.  
Four tubes were filled with 100 μL of distilled water to 
serve as background controls.  One milliliter of Sircol 
dye was added to all tubes, mixed by inversion and then 
placed on an orbital mixer for thirty minutes.  Tubes 
were then centrifuged at 10,000 times gravity for 10 
minutes, the supernatant drained and 1.0 mL alkali 
reagent added.  After mixing, 200 μL of solution from 
each tube was transferred into wells on a new 96 well 
microtiter plate where the absorbance of the samples 
was measured, against the background control, on a 
microtiter plate reader (SpectraMax Plus, Molecular 
Devices Corporation) at a wavelength of 540 nm. 
 
Microscopy Evaluations 
Scaffolds were fixed in 10% formalin solution for 
evaluation by scanning electron microscopy (SEM) and 
histology.  Samples to be evaluated by SEM were 
dehydrated; a representative sample from each scaffold 
was sputter coated in gold (Electron Microscope 
Sciences model 550) for SEM (JEOL JSM-820 JE 
Electron Microscope) and evaluated at 350 to 1500 
times magnification.  Samples for histologic evaluation 
were cross-sectioned for slide mounting and 
hematoxylin and eosin (H&E) staining (Harris 
Histology Relief Services).  H&E slides were evaluated 
by optical light microscopy (Eclipse TE300, Nikon). 
 
Statistics 
All statistical analyses were performed utilizing Sigma 
Stat (Version 2.03; SPSS, Inc).  For the data collected, 
normality and equal variance tests were set to reject for 
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variance tests and were evaluated using a one-way 
analysis of variance (ANOVA) and then subjected to a 
pair-wise multiple comparison procedure (Tukey Test).  
The a priori alpha value was set at 0.05. 
 
RESULTS 
 
Mechanical Evaluation of Electrospun Scaffolds 
Results of mechanical testing of the various electrospun 
fibrinogen-PDO composite structures are presented in 
Figures 3-5.  Properties of pure fibrinogen scaffolds (no 
PDO) were similar to those previously reported [36].  In 
general, values for modulus and peak stress increased 
as PDO concentration increased (Figure 3).  Values for 
strain at failure varied from 84% to 130%, but 
differences were not statistically significant (Figure 4). 
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FIGURE 3: Results of mechanical testing of electrospun fibrinogen-
PDO composite structures are illustrated in terms of modulus of 
elasticity (dark bars) and peak stress (white bars) verses the PDO 
concentrations in the solution from which structures were 
electrospun. 
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FIGURE 4: Results of mechanical testing of electrospun fibrinogen-
PDO composite structures are illustrated in terms of percent strain at 
failure verses the PDO concentrations in the solution from which 
structures were electrospun. 
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FIGURE 5: Modulus of elasticity and peak stress data demonstrate 
the linearity of these values from 0-50% PDO concentration.  The R
2 
value for the linear fit of the curve was 0.977 for modulus and 0.945 
for peak stress. 
 
 
Analysis of modulus of elasticity and peak stress data 
demonstrate the linearity of these values from 0-50% 
PDO concentration (Figure 5) indicating a predictable 
increase in modulus of elasticity and peak stress as 
PDO concentration increases.  The R
2 value for the 
linear fit of the curve was 0.977 for modulus and 0.945 
for peak stress.  An increase in PDO concentration of 
20% and 30% was required to achieve a statistically 
significant increase in peak stress and modulus, 
respectively. 
 
Collagen Assay 
The controls in Figure 6 demonstrate the linearity of 
the assay results from 5 µg to 50 µg.  The R
2 value for 
the linear fit of the standard curve was 0.926 at 7 days 
and 0.991 at 14 days.  Collagen content (Figure 7) was 
calculated from the standard curve in Figure 6.  
Comparison of collagen content at different PDO 
concentrations demonstrated statistically significant 
differences at 7 and 14 days.  Comparison between 
individual groups at day 7 only demonstrated statistical 
significance between the 0% PDO group and the 10% 
and 100% PDO groups.  At 14 days, statistical 
significance was demonstrated between all individual 
groups except between the 10% and 100% PDO groups.  
Comparison of mean collagen content revealed two 
trends.  First, there was a decrease in collagen content 
as PDO concentration increased up to 40% PDO, with 
an increase in collagen content in the 100% PDO group.  
Second, there was a higher collagen content at 7 days 
than at 14 days.  These trends did not hold true for the 
0% PDO concentration at 7 days which had a lower 
than expected collagen content.   
Journal of Engineered Fibers and Fabrics    15  http://www.jeffjournal.org 
Volume 3, Issue 2—2008 All PDO containing scaffolds remained structurally 
intact at 7 days, but areas of broken fibers were 
observed in the 0% PDO group demonstrating some 
early loss of structural integrity.  Varying degrees of 
scaffold fragmentation and fusing of fibers with loss of 
the fibrous architecture were seen in the 0%, 10% and 
20% PDO groups at 14 and 21 days.  All samples in 
these groups were significantly fragmented by 21 days.  
The 40% PDO group maintained its structural integrity 
and fibrous structure throughout the study period. 
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FIGURE 6: Collagen assay controls demonstrating the linearity of the 
assay results from 5 µg to 50 µg.  The R
2 value for the linear fit of the 
standard curve was 0.926 at 7 days and 0.991 at 14 days. 
 
Cell layering is an indicator of the extent to which a 
scaffold is directing cell growth and migration.  Some 
degree of cell layering can be seen in all groups at 7 
days, but it is most pronounced in the 40% PDO group.  
In the 0%, 10% and 20% PDO groups, cell layering is 
substantially decreased at 14 days and almost 
nonexistent at 21 days.  Cell layering remains 
consistent throughout the study period in the 40% PDO 
group.   
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FIGURE 7: Bar graph depicting the collagen assay in terms of 
collagen content (based on the standard curve) for each scaffold 
condition. 
 
Cell spreading is an indicator of the degree to which a 
scaffold supports BSM cells assuming their natural 
morphology.  At 7 days, there is an increase in cell 
spreading in the PDO containing groups compared to 
the 0% PDO group.  This spreading is most pronounced 
in the 40% PDO group.  There is a significant decrease 
in the amount of cell spreading in all groups, except the 
40% PDO group, at 14 days and 21 days 
 
DISCUSSION 
The use of fibrinogen in tissue engineering applications 
is not new.  Fibrinogen hydrogels have received much 
attention because they possess the benefits of 
homogeneous cell distribution and collagen deposition 
[9, 16, 37].  The use of hydrogels for tissue engineering 
requires mixing cells into the fibrinogen solution prior 
to forming the hydrogel.  Electrospun fibrinogen 
scaffolds promote rapid cell migration into the scaffolds 
[35] allowing for cell seeding after scaffold production.  
However, these structures do not possess the structural 
integrity needed for direct implantation.  Electrospun 
PDO structures have greater initial structural integrity 
and take longer to be degraded. The objective of this 
study was to demonstrate that an electrospun 
fibrinogen-PDO composite scaffold would retain the 
superior cellular interaction of fibrinogen while 
producing a product with functional strength for direct 
implantation. 
 
 
Microscopy Evaluations 
SEM analysis of post-cell culture electrospun scaffolds 
demonstrated evidence of cellular activity.  This 
evidence is seen as areas of partial scaffold degradation 
and individual fibers having been pulled out of their 
expected orientation.  Cells were not visible on the 
surface of the scaffolds.   
 
Samples from the H&E stained histological sections are 
presented in Figure 8.  Histological evaluations of 
internal domains of the scaffolds revealed BSM cells 
had migrated into, and appear to be evenly distributed 
throughout, the scaffold thickness in fibrinogen 
containing groups at 7 days, indicating a substantial 
degree of cell migration transpired early in the study 
period.  Further comparison of histologic samples 
revealed two trends.  First, there was an increase in the 
structural integrity of scaffolds as PDO concentrations 
increased.  Second, there was an increase in cell 
layering and cell spreading as PDO concentrations 
increased.  These trends did not hold true for the 100% 
PDO samples where no cells were identified on 
histological examination at any time point. 
 
In this study, mechanical testing data demonstrated that 
increasing the PDO concentration in electrospun 
fibrinogen-PDO composite scaffolds increased strength 
(peak stress) and stiffness (modulus) in a predictable 
fashion. All composite scaffolds maintained similar 
elasticity profiles, indicating composite scaffolds could 
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FIGURE 8: Optical micrographs of hematoxylin and eosin (H&E) stained electrospun fibrinogen-PDO composite scaffolds at 20 times 
magnification.  BSM cells migrated through the full thickness of the scaffolds by day 7 (left column).  Structural integrity of the scaffolds increased 
as PDO concentration increased (top to bottom).  Cell layering and cell spreading also increased as PDO concentration increased. 
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mechanical requirements.   
 
The cell culture data demonstrated several trends 
related to scaffold composition.  First, collagen 
deposition decreased as PDO concentration increased, 
with the exception of the 100% PDO group.  Collagen 
deposition is an indication of the extent to which cells 
are remodeling a scaffold [35].  Second, there was 
increased cell spreading and cell layering at higher 
PDO concentrations.  Cell spreading demonstrates the 
scaffold supports cells assuming their natural 
morphology while cell layering within a scaffold 
demonstrates the scaffold is directing cell growth and 
migration.  Third, higher PDO concentrations produced 
scaffolds with greater structural integrity and stability.  
In general, the higher PDO concentrations produced 
more stable scaffolds that allowed for slower scaffold 
remodeling and stimulated cells to assume a 
morphology closer to their native state.   
 
One of the most attractive aspects of the electrospinning 
process is that scaffolds of various shapes and sizes can 
be constructed while at the same time precisely 
controlling fiber orientation, composition (blended 
fibers), and dimensions.  Complex constructs can be 
fabricated to closely replicate the structural and 
chemical composition of the native structures.  For 
example, flat sheets for on-lay grafts, seamless tubes, or 
any three dimensional shape in which a mandrel can be 
fabricated could be produced.  Also, the ability to co-
spin polymers with various additives (e.g. growth 
factors) offers the possibility of tailoring the scaffold to 
a specific site and application.  Thus, with 
electrospinning, it may be possible to create ideal 
scaffolding for a wide array of tissue  engineering 
applications.  
 
Previous tissue engineered products for urinary tract 
reconstruction have been described utilizing 
decellurized submucosa, natural polymer hydrogels and 
synthetic polymer scaffolds created from a variety of 
production techniques [38-40].  Recent work by Atala 
et al. [41] has even demonstrated the feasibility of 
bladder augmentation with tissue engineered products 
using in vitro cell culture.  This process is labor and 
resource intensive with multiple procedures required to 
harvest cells for in vitro cell culture followed by later 
implantation.  Electrospun scaffolds produced from 
other polymers have also been described for non-
urologic applications [42, 43], but have failed to 
promote the rapid cellular in-growth demonstrated in 
this study.  
 
While an electrospun PDO-elastin composite scaffold 
has been described [44], this is the first report of an 
electrospun fibrinogen-PDO scaffold and the first report 
utilizing an electrospun synthetic and natural polymer 
composite structure for urologic tissue engineering.   
 
CONCLUSION 
This study demonstrates human BSM cells rapidly 
migrate into and remodel an electrospun fibrinogen-
PDO composite scaffold with deposition of native 
collagen.  While there is still much work to be done, 
these initial findings indicate there is tremendous 
potential for electrospun fibrinogen-PDO composite 
structures as urologic tissue engineering scaffolds with 
the ultimate goal of producing an implantable acellular 
product that would promote cellular in-growth and in 
situ tissue regeneration.   
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